SCHEMBL27474246

SCHEMBL27474246

CCN(c1ccccc1)C1CCN(c2ccc(O)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ME3 Q16798 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
DRD4 P21917 1/20 0.44
OPRD1 P41143 2/20 0.42
ME2 P23368 3/20 0.41
ME1 P48163 3/20 0.41
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD1 P21728 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13279486 0.86 ME2 (0.43) ME3DRD4ME2ME1KCNH2
SCHEMBL13279655 0.84 CYP3A4 (0.51) ME3ME2ME1GAAKDM4E
SCHEMBL5543887 0.81 ME3 (0.48) ME3L3MBTL1DRD4ME2ME1
SCHEMBL13282009 0.80 CHRM4 (0.46) CHRM2KCNH2
SCHEMBL5547171 0.79 KDM4E (0.45) ME3DRD4OPRD1DRD3GAA
SCHEMBL27459569 0.77 ESR2 (0.47) KDM4E
SCHEMBL27622558 0.77 OPRM1 (0.49) L3MBTL1OPRD1CHRM2HTR1AADRA2A
SCHEMBL13800059 0.76 OPRM1 (0.49) DRD4OPRD1CHRM2HTR1AADRA2A
SCHEMBL7891539 0.74 MCHR1 (0.56) ME3DRD4ME2ME1SLC6A2
SCHEMBL5539933 0.74 KDM4E (0.49) ME3L3MBTL1DRD4DRD3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed